Design and Application of In Vivo FRET Biosensors to Identify Protein Prenylation and Nanoclustering Inhibitors

M Köhnke, S Schmitt, N Ariotti, AM Piggott, RG Parton, E Lacey, RJ Capon, K Alexandrov, Daniel Abankwa

Tutkimustuotos: LehtiartikkeliArtikkeliTieteellinenvertaisarvioitu

21 Sitaatiot (Scopus)

Abstrakti

Protein prenylation is required for membrane anchorage of small GTPases. Correct membrane targeting is essential for their biological activity. Signal output of the prenylated proto-oncogene Ras in addition critically depends on its organization into nanoscale proteolipid assemblies of the plasma membrane, so called nanoclusters. While protein prenylation is an established drug target, only a handful of nanoclustering inhibitors are known, partially due to the lack of appropriate assays to screen for such compounds. Here, we describe three cell-based high-throughput screening amenable Forster resonance energy transfer NANOclustering and Prenylation Sensors (NANOPS) that are specific for Ras, Rho, and Rab proteins. Rab-NANOPS provides the first evidence for nanoclustering of Rab proteins. Using NANOPS in a cell-based chemical screen, we now identify macrotetrolides, known ionophoric antibiotics, as submicromolar disruptors of Ras nanoclustering and MAPK signaling.
AlkuperäiskieliEi tiedossa
Sivut866–874
Sivumäärä9
JulkaisuChemistry and Biology
Vuosikerta19
Numero7
DOI - pysyväislinkit
TilaJulkaistu - 2012
OKM-julkaisutyyppiA1 Julkaistu artikkeli, soviteltu

Viittausmuodot